To access the full text documents, please follow this link: http://hdl.handle.net/2445/33832

Epidermal growth factor secreted from submandibular salivary glands interferes with the lipolytic effect of adrenaline in mice
Tebar Ramon, Francesc; Grau, M.; Mena Jaramillo, Mari Pau; Arnau, A.; Soley i Farrés, María; Ramírez i Sunyer, Josep Ignasi
Universitat de Barcelona
We had described that epidermal growth factor (EGF) interfered with the lipolytic effect of catecholamines in isolated adipocytes. Since catecholamines stimulate the release of EGF from submandibular salivary glands to blood plasma in male mice, we studied whether EGF affected also the lipolytic response to adrenaline in whole animals. We studied the effect of adrenaline in sialoadenectomized and sham-operated mice receiving or not a high dose of EGF following adrenaline injection. There was no difference in plasma EGF concentration between sham-operated and sialoadenectomized animals receiving saline. After adrenaline administration plasma EGF increased by 20-fold in sham-operated but did not increase in sialoadenectomized mice. Indeed, the increase was much higher (more than 100-fold) in mice receiving exogenous EGF. The effect of adrenaline on plasma concentration of both glycerol and nonesterified fatty acids was higher as lower was plasma EGF concentration. Isolated adipocytes obtained from sham-operated or sialoadenectomized mice had identical lipolytic response to adrenaline. The lipolytic response of adipocytes to isoproterenol was decreased by addition of EGF. To study whether the interference with the in vivo lipolytic effect of adrenaline had further metabolic consequences, we measured plasma b-hydroxybutyrate concentration in plasma. There was no difference in the response to adrenaline between sham-operated and sialoadenectomized mice in spite of the difference in plasma nonsterified fatty acid concentration. Studies in isolated hepatocytes indicated that ketogenesis run at near maximal rate in this range of substrate concentration. These results suggest that EGF in the physiological range decreases the lipolytic effect of adrenaline but does not compromise further metabolic events like the enhancement of ketogenesis.
Saliva
Adrenalina
Factor de creixement epidèrmic
Trastorns del metabolisme dels lípids
Saliva
Adrenaline
Epidermal growth factor
Lipid metabolism disorders
(c) Association for the Study of Internal Secretions, 2000
Article
info:eu-repo/semantics/publishedVersion
Association for the Study of Internal Secretions
         

Show full item record

Related documents

Other documents of the same author

Tebar Ramon, Francesc; Soley i Farrés, María; Ramírez i Sunyer, Josep Ignasi
Sacanella Meseguer, Emilio; Vàzquez Agell, Mònica; Mena Jaramillo, Mari Pau; Antúnez Jorge, Emilia; Fernández-Solà, J. (Joaquim); Nicolás Arfelis, Josep Maria; Lamuela Raventós, Rosa Ma.; Ros Rahola, Emilio; Estruch Riba, Ramon
Sacanella Meseguer, Emilio; Vàzquez Agell, Mònica; Mena Jaramillo, Mari Pau; Antúnez Jorge, Emilia; Fernández-Solà, J. (Joaquim); Nicolás Arfelis, Josep Maria; Lamuela Raventós, Rosa Ma.; Ros Rahola, Emilio; Estruch Riba, Ramon
Jaafari, N.; Fernández de la Cruz, L.; Grau, M.; Knowles, E.; Radua, J.; Wooderson, S.; Segalàs, Cinto; Alonso Ortega, María del Pino; Phillips, M. L.; Menchón Magriñá, José Manuel; Mataix-Cols, D.
Jaafari, N.; Fernández de la Cruz, L.; Grau, M.; Knowles, E.; Radua, J.; Wooderson, S.; Segalàs, Cinto; Alonso Ortega, María del Pino; Phillips, M. L.; Menchón Magriñá, José Manuel; Mataix-Cols, D.
 

Coordination

 

Supporters